共 50 条
- [1] Durable Clinical Remission and Response in Adalimumab-Treated Patients with Ulcerative Colitis [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S256 - S257
- [9] Adalimumab maintains remission for up to 4 years in patients with ulcerative colitis [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S306 - S306
- [10] Adalimumab in patients with ulcerative colitis [J]. ANNALS OF GASTROENTEROLOGY, 2010, 23 (01): : 64 - 66